IONIS-GCGRRx
/ Ionis, Suzhou Ribo
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 19, 2024
The efficacy and safety of ISIS 449884 injection as monotherapy in patients with type 2 diabetes: A randomized phase II study.
(PubMed, Diabetes Obes Metab)
- No abstract available
Journal • Monotherapy • P2 data • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
July 15, 2024
ISIS 449884 Injection Add-On to Metformin in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase II Clinical Study.
(PubMed, Diabetes Ther)
- "The ISIS 449884 injection add-on to metformin significantly reduced HbA1c in patients with T2DM uncontrolled by stable metformin monotherapy and showed an acceptable benefit/risk profile."
Clinical • Journal • P2 data • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
1 to 2
Of
2
Go to page
1